SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-18-000372
Filing Date
2018-01-03
Accepted
2018-01-03 11:19:32
Documents
2
Period of Report
2017-12-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3109
2 POWER OF ATTORNEY (PUBLIC): ROBERTSON POA doc1.txt EX-24 3469
  Complete submission text file 0001127602-18-000372.txt   8161
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807
Business Address
ROBERTSON RUSSEL C (Reporting) CIK: 0001677301 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 18503851